UnknownPHASE2, PHASE3NCT05618470
Wumeiwan Jiawei Fang Use in Patients With Blepharospasm
Studying Blepharospasm-oromandibular dystonia syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- China Academy of Chinese Medical Sciences
- Principal Investigator
- wei yangChina Academy of Chinese Medical Sciences
- Intervention
- Wumeiwan Jiawei Fang(drug)
- Enrollment
- 80 enrolled
- Eligibility
- 18-80 years · All sexes
- Timeline
- 2018 – 2024
Study locations (1)
- Eye Hospital, China Academy of Chinese Medical Sciences；GuangAnmen Hospital, China Academy of Chinese Medical Sciences；XiYuan Hospital, China Academy of Chinese Medical Sciences, Beijing, Beijing Municipality, China
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05618470 on ClinicalTrials.govOther trials for Blepharospasm-oromandibular dystonia syndrome
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT06912282Bilateral Single-Electrode VO Combined With STN-DBS for Treating Meige SyndromeHuashan Hospital
- RECRUITINGNCT03042962Brain Networks in DystoniaMassachusetts Eye and Ear Infirmary
See all trials for Blepharospasm-oromandibular dystonia syndrome →